Danaher Corporation $DHR Shares Purchased by Van ECK Associates Corp

Van ECK Associates Corp raised its position in Danaher Corporation (NYSE:DHR) by 5.2% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 1,728,070 shares of the conglomerate’s stock after buying an additional 85,460 shares during the quarter. Van ECK Associates Corp owned about 0.24% of Danaher worth $342,607,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. WFA of San Diego LLC acquired a new stake in Danaher in the second quarter valued at about $26,000. Howard Hughes Medical Institute purchased a new position in Danaher in the second quarter worth $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher during the third quarter worth about $27,000. TruNorth Capital Management LLC purchased a new position in Danaher in the third quarter valued at about $28,000. Finally, Tripletail Wealth Management LLC purchased a new stake in shares of Danaher during the 3rd quarter worth approximately $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the sale, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 11.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on DHR. Jefferies Financial Group upped their target price on Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. TD Cowen reissued a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Robert W. Baird set a $251.00 price objective on Danaher in a research report on Thursday, January 29th. Finally, JPMorgan Chase & Co. increased their price objective on Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research note on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $253.86.

Danaher Stock Up 1.7%

DHR stock opened at $198.85 on Tuesday. The company has a 50 day moving average price of $221.89 and a two-hundred day moving average price of $215.95. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The stock has a market capitalization of $140.62 billion, a P/E ratio of 39.45, a PEG ratio of 2.64 and a beta of 0.93. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same quarter in the prior year, the company posted $2.14 EPS. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. As a group, sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.8%. This is a boost from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date is Friday, March 27th. Danaher’s dividend payout ratio (DPR) is currently 25.40%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.